Navigation Links
Alfacell Reports Financial Results for First Quarter of Fiscal 2008
Date:12/10/2007

45-4271 212-845-4253

David.Schull@russopartnersllc.com Andreas.Marathis@russopartnersllc.com

Wendy.Lau@russopartnersllc.com

ALFACELL CORPORATION

Condensed Statements of Operations

(Unaudited)

Three-Months Ended

October 31

2007 2006

Revenues $- $-

Expenses:

Research and development 1,615,791 1,570,185

General and administrative 1,171,516 926,038

Total expenses 2,787,307 2,496,223

Loss from operations (2,787,307) (2,496,223)

Interest income, net 60,507 123,287

State tax benefit - -

Net loss $(2,726,800) $(2,372,936)

Net loss per common share-basic and diluted $(0.06) $(0.05)

Shares used in computation of net loss per

common share:

Basic and diluted 46,430,000 44,346,000

Balance Sheet Data:

October 31, July 31,

2007 2007

Cash and cash equivalents $5,397,768 $6,968,172

Total assets $6,425,242 $7,820,499

Current l
'/>"/>

SOURCE Alfacell Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... MISSISSAUGA,Ontario,Nov.24/PRNewswire-FirstCall/-...developeroftechnologyandproductstargetingtheimmuno...ChimieS.A.S.("MerckChimie")isprogressingtothenextp...rysilvercoatedparamagneticBeads("Beads"). ,, Pe...thisyear,CardioGenicssuppliedMerckChimiewithitspro...
(Date:11/24/2009)... BEIJING,Nov.24/PRNewswire-Asia-FirstCall/--LotusP..."orthe"Company")agrowingdeveloperand,producerofpre...utical,productsinthePeople,sRepublicChina,todayrep...heBeijingpharmaceuticaldelegation. ,, Time:No...ionCenter,Chengdu ,, TheBeijingdelegationfeat...
(Date:11/24/2009)... WAYNE,N.J.,Nov.24/PRNewswire/--MAQUETCardiovascul...,announcedtodaythatithassignedaguaranteedtwo-yearc...rchasingorganizations,tobethesolesourceproviderofs... Underthetermsoftheagreement,whichrunsthroughOctob...oviderofbeatingheartdevicesanddisposablesuppliesto...
Breaking Medicine Technology:CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 1Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 2Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 1Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 1Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 4Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 5Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 6Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 7Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 8
...Micromet, Inc. (Nasdaq: MITI ), a biopharmaceuti...es for the treatment of cancer, inflammation and a...tered into an agreement expanding its Committed Eq...pital Limited, a private investment group. Under ...ted to provide up to $75 million of capital during...
...eGen has announced that an oral,presentation of p...linical,trial of TG101348 in myeloproliferative di...ican Society of Hematology (ASH) Meeting. , , ...itle: A Phase I Study of TG101348, an...Selective Inhibitor, in Patients with, ...
Other Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6
(Date:11/24/2009)..., New York personal injur...e to have the number of a personal injury attorney...ands in a local Long Island backyard. , ...009 -- New York personal injury attorney David P...r that everyone should have the number of a person...
(Date:11/24/2009)..., Mercy Health System wil...ASIK surgery hosted by Robert Epstein, MD, board c...ery. Register today at www.MercyWebinars.com , ...-- Mercy Health System will present a live webinar...ccessed through an office or home computer and is ...
(Date:11/24/2009)...,, SOMERSET,N.J.,Nov.24/PRNewswire-FirstCall...fhealthcareandadministrativestaffingservices,today...tscommonstockfromTheNasdaqGlobalMarkettoTheNasdaqC...llbeeffectiveattheopeningofbusinessonWednesday,Nov...etotradeunderthesymbol"TSTF."TheNasdaqCapitalMarke...
(Date:11/24/2009)...,, MORRISVILLE,N.C.,Nov.24/PRNewswire/--TheA...einitialresultsofasurveyabouttheimpactofthe2010CMS...the1,200cardiologistsandcardiovascularultrasoundte...uldforcethemtostopacceptingMedicarepatients,reduce...reducingpatientaccesstoechocardiography(heartultra...
(Date:11/24/2009)... Exposure in infancy may lead to persistent wheezi...althDay News) -- Infants exposed to outdoor traffi...risk for asthma, researchers say. , Endotoxin -...mmune response in humans -- is found in dust. ,...archers found persistent wheezing (an early warnin...
Breaking Medicine News(10 mins):Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 2Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 3Health News:Free LASIK Surgery Webinar 2Health News:Free LASIK Surgery Webinar 3Health News:Free LASIK Surgery Webinar 4Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 2Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 3Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2Health News:Traffic, Dust Linked to Asthma in Kids 2
...demand for Palliative care for treatment of chroni...vey of Hospitals, which has been reported in the J...s given to patients where chemotherapy or other tr...n demand for palliative care. Palliative care pr...
...ts in the US and Canada are looking to India to pr...sorders.// "Our consortium is trying to netwo...ent and devices in India," John Remmers, a pioneer... as the father of sleep medicine, and his associat...
...the in the January 15, 2006 issue of CANCER, the j...he prostate specific antigen (PSA) test is subject..., race, and diet. // This could lead to false p...A velocity, which is calculated as the rate of cha...
...he Communication in-charge of the Global Alliance ...ess conference in New Delhi, stated that The Globa...dollars.// Global Health Bonds are the first o... gross 3-4% interest. It is an opening for the...
...n are required for immunizing the most deprived ch...evyt of the Global Alliance for Vaccines and Immun...ired to be spent on vaccines alone. This will serv...s, 400 public health experts, and representatives ...
...Sunday five new suspected cases of avian flu in do...lta, where the deadly virus was first isolated in ... samples taken from dead poultry in a village of P...rds in more than a dozen villages in and around th...
Other Medicine News:Health News:Cheap Indian devices sought to treat sleep disorder 2Health News:Prostate Cancer Test Is Influenced By Age and Nutrition Factors 2Health News:More Funds Are Required For Immunisation Drive 2
FLEXILOG 2000 Pouch and Belt
pH Calibration Kit (pH1.07 and pH7.01)
13848 Buffer Solution pH 4.00 (250ml)
13847 Buffer Solution pH 1.07 (250ml)
Medicine Products: